X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (32) 32
cardiac & cardiovascular systems (27) 27
female (26) 26
male (26) 26
adult (22) 22
middle aged (14) 14
hypertension, pulmonary - drug therapy (12) 12
index medicus (11) 11
adolescent (10) 10
survival (10) 10
treatment outcome (10) 10
epoprostenol (9) 9
child (7) 7
epoprostenol - administration & dosage (7) 7
hypertension, pulmonary - physiopathology (7) 7
living donors (7) 7
lung transplantation (7) 7
pulmonary hypertension (7) 7
antihypertensive agents - therapeutic use (6) 6
echocardiography (6) 6
prostacyclin (6) 6
aged (5) 5
antihypertensive agents - administration & dosage (5) 5
apoptosis (5) 5
hemodynamics - drug effects (5) 5
idiopathic pulmonary arterial hypertension (5) 5
oxidative stress (5) 5
pulmonary arterial hypertension (5) 5
therapy (5) 5
animals (4) 4
antihypertensive agents - adverse effects (4) 4
arterial-hypertension (4) 4
cardiac catheterization (4) 4
cardiology (4) 4
cardiovascular (4) 4
electrocardiography (4) 4
epoprostenol - therapeutic use (4) 4
hypertension, pulmonary - complications (4) 4
hypertension, pulmonary - etiology (4) 4
hypertension, pulmonary - therapy (4) 4
infusion (4) 4
pulmonary artery - drug effects (4) 4
pulmonary artery - pathology (4) 4
pulmonary artery - physiopathology (4) 4
retrospective studies (4) 4
vasodilator agents - therapeutic use (4) 4
young adult (4) 4
antioxidants (3) 3
arteriovenous anastomosis - diagnostic imaging (3) 3
astaxanthin (3) 3
atrophy (3) 3
blood flow velocity (3) 3
blood pressure (3) 3
cardiology and cardiovascular medicine (3) 3
cells, cultured (3) 3
dietary supplements (3) 3
dose-response relationship, drug (3) 3
echocardiography, transesophageal (3) 3
epoprostenol - adverse effects (3) 3
heart failure (3) 3
hemangioma, capillary - drug therapy (3) 3
hemangioma, capillary - physiopathology (3) 3
hypertension, pulmonary (3) 3
hypertension, pulmonary - blood (3) 3
hypertension, pulmonary - pathology (3) 3
immunohistochemistry (3) 3
injections, intravenous (3) 3
japan (3) 3
lung neoplasms - drug therapy (3) 3
lung neoplasms - physiopathology (3) 3
medicine & public health (3) 3
muscles (3) 3
myocardium - metabolism (3) 3
natriuretic peptide, brain - blood (3) 3
peripheral vascular disease (3) 3
physiology (3) 3
primary pulmonary hypertension (3) 3
pulmonary veins - diagnostic imaging (3) 3
rats (3) 3
rats, wistar (3) 3
recurrence (3) 3
respiratory system (3) 3
rodents (3) 3
severity of illness index (3) 3
supplementation (3) 3
transplantation of organs, tissues, etc (3) 3
treatment failure (3) 3
vascular resistance (3) 3
vasodilator agents - adverse effects (3) 3
acute myocardial-infarction (2) 2
acute vasoreactivity testing (2) 2
adenosine (2) 2
angiography (2) 2
antioxidant (2) 2
antioxidants - pharmacology (2) 2
antioxidants - therapeutic use (2) 2
apoptosis - drug effects (2) 2
arrhythmia (2) 2
arterial pressure (2) 2
article (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Respiratory Medicine, ISSN 0954-6111, 10/2017, Volume 131, pp. 215 - 219
Pulmonary veno-occlusive disease (PVOD) and pulmonary capillary hemangiomatosis (PCH) are categorized as Group 1′ in the clinical classification of pulmonary... 
Epoprostenol | HRCT | Treatment | Hemodynamics | Pulmonary arterial pressure | Survival | DIAGNOSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | RESPIRATORY SYSTEM | ARTERIAL-HYPERTENSION | TRANSPLANTATION | Lung Neoplasms - drug therapy | Humans | Middle Aged | Hemangioma, Capillary - blood | Hypertension, Pulmonary - physiopathology | Male | Hypertension, Pulmonary - blood | Lung Neoplasms - physiopathology | Pulmonary Veno-Occlusive Disease - drug therapy | Young Adult | Hemangioma, Capillary - drug therapy | Imatinib Mesylate - therapeutic use | Lung Transplantation | Adult | Hypertension, Pulmonary - drug therapy | Natriuretic Peptide, Brain - blood | Severity of Illness Index | Pulmonary Veno-Occlusive Disease - physiopathology | Kaplan-Meier Estimate | Hemangioma, Capillary - physiopathology | Survival Rate | Treatment Outcome | Protein Kinase Inhibitors - therapeutic use | Exercise Tolerance | Lung Neoplasms - blood | Pulmonary Veno-Occlusive Disease - blood | Walk Test | Antimitotic agents | Evaluation | Hemangioma | Care and treatment | Antineoplastic agents | Pulmonary hypertension | Medical research | Cardiac patients | Medicine, Experimental | Transplantation of organs, tissues, etc | Rankings | Natriuretic peptides | Brain | Therapy | Syngeneic grafts | Lung transplantation | Transplantation | Veno-occlusive disease | Confidence intervals | Blood pressure | Safety | Heart diseases | Drug dosages | Hypertension | Brain natriuretic peptide | Edema | Imatinib | Brain architecture | Pulmonary arteries | Lung diseases | Patients | Heart rate | Survival analysis | Functional morphology | Medical prognosis | Respiration
Journal Article
Journal Article
Life Sciences, ISSN 0024-3205, 12/2013, Volume 93, Issue 25-26, pp. e33 - e33
Journal Article
Journal Article
Journal Article
Circulation Journal, ISSN 1346-9843, 2012, Volume 76, Issue 7, pp. 1729 - 1736
Background: Pulmonary veno-occlusive disease (PVOD) and pulmonary capillary hemangiomatosis (PCH) are rare causes of pulmonary hypertension. There is no proven... 
Pulmonary veno-occlusive disease | Epoprostenol | Pulmonary capillary hemangiomatosis | Pulmonary hypertension | Pulmonary venoocclusive disease | SURVIVAL | LOBAR LUNG TRANSPLANTATION | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | PROSTACYCLIN | EDEMA | ARTERIAL-HYPERTENSION | CLINICAL CLASSIFICATION | PATIENT | Lung Neoplasms - drug therapy | Hypertension, Pulmonary - diagnosis | Vasodilator Agents - therapeutic use | Humans | Hemangioma, Capillary - blood | Hypertension, Pulmonary - physiopathology | Male | Hypertension, Pulmonary - blood | Lung Neoplasms - physiopathology | Exercise Tolerance - drug effects | Pulmonary Veno-Occlusive Disease - drug therapy | Recovery of Function | Epoprostenol - therapeutic use | Hemangioma, Capillary - drug therapy | Lung Transplantation | Time Factors | Hemangioma, Capillary - diagnosis | Epoprostenol - adverse effects | Vascular Resistance - drug effects | Adult | Female | Blood Pressure - drug effects | Hypertension, Pulmonary - drug therapy | Child | Natriuretic Peptide, Brain - blood | Pulmonary Veno-Occlusive Disease - complications | Hemangioma, Capillary - complications | Pulmonary Veno-Occlusive Disease - physiopathology | Japan | Hemangioma, Capillary - physiopathology | Treatment Outcome | Biomarkers - blood | Antihypertensive Agents - therapeutic use | Antihypertensive Agents - adverse effects | Lung Neoplasms - complications | Adolescent | Lung Neoplasms - blood | Pulmonary Veno-Occlusive Disease - blood | Vasodilator Agents - adverse effects | Lung Neoplasms - diagnosis | Hypertension, Pulmonary - etiology
Journal Article
Journal of Cardiac Failure, ISSN 1071-9164, 2012, Volume 18, Issue 10, pp. S131 - S131
Journal Article
Journal of Pharmacological Sciences, ISSN 1347-8613, 2012, Volume 120, Issue 3, pp. 206 - 212
Journal Article
Journal Article
Internal Medicine, ISSN 0918-2918, 2014, Volume 53, Issue 6, pp. 603 - 607
A 43-year-old man presented with dyspnea on exertion. Right heart catheterization demonstrated pulmonary arterial hypertension (PAH). He was treated with... 
imatinib | tyrosine kinase inhibitor | pulmonary capillary hemangiomatosis | pulmonary hypertension | Imatinib | Tyrosine kinase inhibitor exertion. he had worked as a carpenter two years earlier | Pulmonary capillary hemangiomatosis | Pulmonary hypertension | MESYLATE | MEDICINE, GENERAL & INTERNAL | VENOOCCLUSIVE DISEASE | PATHWAY | TONE | ARTERIAL-HYPERTENSION | KINASE | GROWTH-FACTOR | Hemangioma, Capillary - pathology | Piperazines - administration & dosage | Lung Neoplasms - drug therapy | Humans | Lung Neoplasms - pathology | Male | Dyspnea - etiology | Antineoplastic Agents - administration & dosage | Lung Neoplasms - physiopathology | Purines - administration & dosage | Sildenafil Citrate | Hemangioma, Capillary - drug therapy | Benzamides - administration & dosage | Cardiac Catheterization | Bosentan | Autopsy | Hemangioma, Capillary - diagnosis | Treatment Failure | Fatal Outcome | Adult | Hypertension, Pulmonary - drug therapy | Lung - pathology | Echocardiography | Pyrimidines - administration & dosage | Hemangioma, Capillary - physiopathology | Lung - physiopathology | Antihypertensive Agents - therapeutic use | Imatinib Mesylate | Radiography, Thoracic | Lung Neoplasms - diagnosis | Sulfonamides - administration & dosage | Epoprostenol - administration & dosage | Hypertension, Pulmonary - complications | Index Medicus
Journal Article